A new study to be conducted in South Africa, Uganda and India has sparked a heated debate in the HIV activist and research community.
The hunt is on for a new private sector partner with the expertise to set up a drug-making plan.
Access to ARVs is improving, but poor attitudes to patients are aggravating maternal mortality rates.
As the fallout regarding misinformation about vaccines and antiretrovirals shows, words can kill.
Patients go without key drugs as the province and suppliers trade blame for antiretroviral shortages.
New medicine combines ARVs into one pill, making them easier to supply.
ARVs have slowed down the rate of new HIV infections and increased the life expectancy of the general population in rural KZN
Hundreds of people with HIV took to the streets of Swaziland to protest over poor health service delivery and a reported shortage of ARV treatment.
Health economists say increasing the uptake of antiretroviral treatment to meet the state's targets will require an additional R10bn a year in funding
People in need of treatment are dying because hospitals are desperate for funds, writes Xolile Ntutu
The Global Fund to Fight Aids, Malaria and TB, the largest funder of Aids programmes worldwide, has an estimated shortfall of $3-billion to $5-billion